Given the pleiotropic nature of IL-33, these findings when taken together could suggest that IL-33 activity on ST2+ cells may contribute to the development of severe cerebral malaria, while IL-33 activity may induce a therapeutic effect outside of the IL-33/ST2 axis. The gene discussed is IL33; the disease is cerebral malaria.